AUD 0.8
(2.56%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 | 1.95 Million AUD | 24.46% |
2023 | 1.57 Million AUD | 70.0% |
2022 | 923.62 Thousand AUD | 100.7% |
2021 | 460.2 Thousand AUD | 28.4% |
2020 | 358.42 Thousand AUD | 64.83% |
2019 | 217.45 Thousand AUD | -51.46% |
2018 | 447.98 Thousand AUD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q3 | 1.95 Million AUD | 243.77% |
2024 Q2 | 568.49 Thousand AUD | 21.76% |
2024 Q4 | 1.95 Million AUD | 0.0% |
2024 FY | 1.95 Million AUD | 24.46% |
2024 Q1 | 466.9 Thousand AUD | -49.45% |
2023 Q1 | 1.31 Million AUD | 42.75% |
2023 Q2 | 1.64 Million AUD | 24.66% |
2023 FY | 1.57 Million AUD | 70.0% |
2023 Q4 | 923.62 Thousand AUD | -24.77% |
2023 Q3 | 1.22 Million AUD | -25.3% |
2022 Q1 | 905.83 Thousand AUD | 96.83% |
2022 Q4 | 923.62 Thousand AUD | 0.0% |
2022 FY | 923.62 Thousand AUD | 100.7% |
2022 Q3 | 923.62 Thousand AUD | -0.24% |
2022 Q2 | 925.84 Thousand AUD | 2.21% |
2021 Q1 | 240.79 Thousand AUD | -75.64% |
2021 FY | 460.2 Thousand AUD | 28.4% |
2021 Q4 | 460.2 Thousand AUD | 1.3% |
2021 Q3 | 454.31 Thousand AUD | 85.53% |
2021 Q2 | 244.87 Thousand AUD | 1.69% |
2020 FY | 358.42 Thousand AUD | 64.83% |
2020 Q4 | 988.42 Thousand AUD | 0.0% |
2020 Q3 | 988.42 Thousand AUD | 0.0% |
2020 Q1 | - AUD | 0.0% |
2019 FY | 217.45 Thousand AUD | -51.46% |
2018 FY | 447.98 Thousand AUD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Althea Group Holdings Limited | 23.33 Million AUD | 91.626% |
Cann Group Limited | 78.85 Million AUD | 97.521% |
ECS Botanics Holdings Ltd | 4.66 Million AUD | 58.14% |
Ecofibre Limited | 30.27 Million AUD | 93.546% |
Elixinol Wellness Limited | 5.24 Million AUD | 62.768% |
Hygrovest Limited | 2.68 Million AUD | 27.105% |
IDT Australia Limited | 7.93 Million AUD | 75.355% |
Invion Limited | 1.01 Million AUD | -92.768% |
Little Green Pharma Ltd | 16.39 Million AUD | 88.077% |
Medical Developments International Limited | 13.42 Million AUD | 85.445% |
Vitura Health Limited | 32.83 Million AUD | 94.049% |
Vita Life Sciences Limited | 16.47 Million AUD | 88.138% |